Monthly Archives: January 2011

LRG responds to recent Cancer Cell coverage

Yesterday, there were a series of news stories reporting on an article published by Cooke et al inCancer Cell. Unfortunately, the coverage gave misleading information which could suggest that patients should not take Gleevec (imatinib) or Sutent (sunitinib).

By |2014-09-17T10:15:35-04:00January 19th, 2011|News|

Robert “Butch” Eller – In Memoriam

Robert “Butch” W. Eller, age 66 of Pennsville, NJ, passed into heaven on Wednesday, January 19, 2011 at his residence surrounded by his “Little Darlin” and wife, Jeanie, and loving son, Ryan, as well as family and close friends. Butch was diagnosed with the rare cancer (GIST) Gastro-Intestinal Stromal Tumor in November of 2003.

By |2014-09-17T10:15:35-04:00January 19th, 2011|In Memoriam|

PDGFRA Mutations: It’s time to consider mutational status for resistant GIST patients

January 6th, 2011 - By Jerry Call,  LRG Science CoordinatorThe first ever clinical trial specifically for the PDGFRA D842V mutation has been announced by Arog pharmaceuticals. The phase II trial is scheduled to open in [...]

New Treatments of D842V Mutations

 UPDATE - January 6th, 2011 by Jerry Call, LRG Science Coordinator The first ever clinical trial specifically for the PDGFRA D842V mutation has been announced by Arog pharmaceuticals. The phase II trial is scheduled [...]

By |2019-04-03T12:02:19-04:00January 6th, 2011|Clinical Trials, D842V, Diagnosis, Mutational Testing, Mutations, News, Research|
Go to Top